Hepatoblastoma

cancer family

Identifier: CI-CAN-00000199
Entity page: /cancer/hepatoblastoma ↗
Edges: 118

Neighbours: 18 drugs10 trials
Drawn: 28 of 28 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Hepatoblastoma investigated for …INVESTIGATED_FOR14 of 14
← investigated for	Vincristinesmall_molecule	unknown	3	Hepatoblastoma	1	Curated	chembl	graph →
← investigated for	Temsirolimussmall_molecule	unknown	3

Hepatoblastoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 43show all (up to 200)
→ investigated in trials for	Carboplatinsmall_molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall_molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall_molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall_molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall_molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall_molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ensartinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall_molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ivosidenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hepatoblastoma	2	Observed	clinicaltrials	graph →

Hepatoblastoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 43show all (up to 200)

→ investigated in trials for

Carboplatinsmall_molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Hepatoblastoma studied in …STUDIED_INderived10 of 61show all (up to 200)
→ studied in	NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped CURATED_BROADER · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03959800recruiting Molecular Basis of Pediatric Liver Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 61 trials mapped (29 active)	—	—	Hepatoblastoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains